Journal of General Virology, Vol 78, 677-685, Copyright © 1997 by Society for General Microbiology

ARTICLES

Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta- converting enzyme and protects virus-infected cells from TNF- and Fas- mediated apoptosis, but does not prevent IL-1beta-induced fever

S Kettle, A Alcami, A Khanna, R Ehret, C Jassoy and GL Smith
Sir William Dunn School of Pathology, University of Oxford, UK.

The vaccinia virus (VV) strain Western Reserve B13R gene encodes a 38.5 kDa intracellular polypeptide that is non-essential for virus replication in vitro and does not affect virus virulence in a murine intranasal model. The protein has 92% amino acid identity with the cowpox virus cytokine response modifier A (crmA) protein which inhibits the interleukin (IL)-1beta converting enzyme (ICE). Here, we show that extracts from THP-1 cells infected with VV strains expressing B13R prevent the cleavage of in vitro transcribed and translated pro-IL- 1beta into mature IL-1beta. Similarly, THP-1 cells infected with VVs expressing B13R process pro-IL-1beta into mature IL-1beta inefficiently in situ. Despite its inhibition of ICE, B13R does not prevent fever in infected mice, a systemic effect mediated by IL-1beta. Instead, fever is controlled by the VV IL-1beta receptor, encoded by gene B15R, and deletion of both the B13R and B15R genes did not increase the febrile response compared to deletion of B15R alone. The B13R protein does, however, block apoptosis mediated by anti-Fas antibodies or by tumour necrosis factor (TNF) and cycloheximide. Using DNA fragmentation, chromium release and microscopic analyses it was shown that cells infected with wild-type VV strain WR, or a revertant virus in which the B13R gene had been re-inserted into the B13R deletion mutant, are more resistant than uninfected cells or deletion mutant-infected cells to apoptosis mediated by anti-Fas and TNF.

This article has been cited by other articles:

				S. Nie, M. Cornberg, and L. K. Selin Resistance to Vaccinia Virus Is Less Dependent on TNF under Conditions of Heterologous Immunity J. Immunol., November 15, 2009; 183(10): 6554 - 6560. [Abstract] [Full Text] [PDF]

				A. S. Fahy, R. H. Clark, E. F. Glyde, and G. L. Smith Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence J. Gen. Virol., October 1, 2008; 89(10): 2377 - 2387. [Abstract] [Full Text] [PDF]

				A. Garcel, J.-M. Crance, R. Drillien, D. Garin, and A.-L. Favier Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses J. Gen. Virol., July 1, 2007; 88(7): 1906 - 1916. [Abstract] [Full Text] [PDF]

				A. Chahroudi, D. A. Garber, P. Reeves, L. Liu, D. Kalman, and M. B. Feinberg Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus ankara and vaccinia virus. J. Virol., September 1, 2006; 80(17): 8469 - 8481. [Abstract] [Full Text] [PDF]

				R. A.-J. Chen, N. Jacobs, and G. L. Smith Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor J. Gen. Virol., June 1, 2006; 87(6): 1451 - 1458. [Abstract] [Full Text] [PDF]

				P. M. Beard, G. C. Froggatt, and G. L. Smith Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model J. Gen. Virol., June 1, 2006; 87(6): 1521 - 1529. [Abstract] [Full Text] [PDF]

				J. L. Najera, C. E. Gomez, E. Domingo-Gil, M. M. Gherardi, and M. Esteban Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene. J. Virol., June 1, 2006; 80(12): 6033 - 6047. [Abstract] [Full Text] [PDF]

				W.-H. Liu, Y.-L. Lin, J.-P. Wang, W. Liou, R. F. Hou, Y.-C. Wu, and C.-L. Liao From the Cover: Restriction of vaccinia virus replication by a ced-3 and ced-4-dependent pathway in Caenorhabditis elegans. PNAS, March 14, 2006; 103(11): 4174 - 4179. [Abstract] [Full Text] [PDF]

				L. Ford, D. B. Guiliano, Y. Oksov, A. K. Debnath, J. Liu, S. A. Williams, M. L. Blaxter, and S. Lustigman Characterization of a Novel Filarial Serine Protease Inhibitor, Ov-SPI-1, from Onchocerca volvulus, with Potential Multifunctional Roles during Development of the Parasite J. Biol. Chem., December 9, 2005; 280(49): 40845 - 40856. [Abstract] [Full Text] [PDF]

				Z. S. Guo, A. Naik, M. E. O'Malley, P. Popovic, R. Demarco, Y. Hu, X. Yin, S. Yang, H. J. Zeh, B. Moss, et al. The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2 Cancer Res., November 1, 2005; 65(21): 9991 - 9998. [Abstract] [Full Text] [PDF]

				R. Nathaniel, A. L. MacNeill, Y.-X. Wang, P. C. Turner, and R. W. Moyer Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections J. Gen. Virol., May 1, 2004; 85(5): 1267 - 1278. [Abstract] [Full Text] [PDF]

				S. C. Pak, V. Kumar, C. Tsu, C. J. Luke, Y. S. Askew, D. J. Askew, D. R. Mills, D. Bromme, and G. A. Silverman SRP-2 Is a Cross-class Inhibitor That Participates in Postembryonic Development of the Nematode Caenorhabditis elegans: INITIAL CHARACTERIZATION OF THE CLADE L SERPINS J. Biol. Chem., April 9, 2004; 279(15): 15448 - 15459. [Abstract] [Full Text] [PDF]

				F. A. Legrand, P. H. Verardi, L. A. Jones, K. S. Chan, Y. Peng, and T. D. Yilma Induction of Potent Humoral and Cell-Mediated Immune Responses by Attenuated Vaccinia Virus Vectors with Deleted Serpin Genes J. Virol., March 15, 2004; 78(6): 2770 - 2779. [Abstract] [Full Text] [PDF]

				P. C. Reading and G. L. Smith Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity J. Virol., September 15, 2003; 77(18): 9960 - 9968. [Abstract] [Full Text] [PDF]

				M. M. Gherardi, J. C. Ramirez, and M. Esteban IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system J. Gen. Virol., August 1, 2003; 84(8): 1961 - 1972. [Abstract] [Full Text] [PDF]

				J. B. Johnston and G. McFadden Poxvirus Immunomodulatory Strategies: Current Perspectives J. Virol., June 1, 2003; 77(11): 6093 - 6100. [Full Text] [PDF]

				M. C. Ramirez and L. J. Sigal Macrophages and Dendritic Cells Use the Cytosolic Pathway to Rapidly Cross-Present Antigen from Live, Vaccinia-Infected Cells J. Immunol., December 15, 2002; 169(12): 6733 - 6742. [Abstract] [Full Text] [PDF]

				J. A. Symons, E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G. L. Smith The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model J. Gen. Virol., November 1, 2002; 83(11): 2833 - 2844. [Abstract] [Full Text] [PDF]

				D. C. Tscharke, P. C. Reading, and G. L. Smith Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes J. Gen. Virol., August 1, 2002; 83(8): 1977 - 1986. [Abstract] [Full Text] [PDF]

				S. Hay and G. Kannourakis A time to kill: viral manipulation of the cell death program J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564. [Abstract] [Full Text] [PDF]

				N. Price, D. C. Tscharke, and G. L. Smith The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence J. Gen. Virol., April 1, 2002; 83(4): 873 - 878. [Abstract] [Full Text] [PDF]

				S. T. Wasilenko, A. F. A. Meyers, K. Vander Helm, and M. Barry Vaccinia Virus Infection Disarms the Mitochondrion-Mediated Pathway of the Apoptotic Cascade by Modulating the Permeability Transition Pore J. Virol., December 1, 2001; 75(23): 11437 - 11448. [Abstract] [Full Text]

				X. Zang, A. K. Atmadja, P. Gray, J. E. Allen, C. A. Gray, R. A. Lawrence, M. Yazdanbakhsh, and R. M. Maizels The Serpin Secreted by Brugia malayi Microfilariae, Bm-SPN-2, Elicits Strong, but Short-Lived, Immune Responses in Mice and Humans J. Immunol., November 1, 2000; 165(9): 5161 - 5169. [Abstract] [Full Text] [PDF]

				M. Li and A. A. Beg Induction of Necrotic-Like Cell Death by Tumor Necrosis Factor Alpha and Caspase Inhibitors: Novel Mechanism for Killing Virus-Infected Cells J. Virol., August 15, 2000; 74(16): 7470 - 7477. [Abstract] [Full Text]

				M. Barry, J. A. Heibein, M. J. Pinkoski, S.-F. Lee, R. W. Moyer, D. R. Green, and R. C. Bleackley Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid Mol. Cell. Biol., June 1, 2000; 20(11): 3781 - 3794. [Abstract] [Full Text]

				D. J. Brick, R. D. Burke, A. A. Minkley, and C. Upton Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis J. Gen. Virol., April 1, 2000; 81(4): 1087 - 1097. [Abstract] [Full Text]

				G. Herbein and W. A. O'brien Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis Experimental Biology and Medicine, March 1, 2000; 223(3): 241 - 257. [Abstract] [Full Text]

				J. Engelmayer, M. Larsson, M. Subklewe, A. Chahroudi, W. I. Cox, R. M. Steinman, and N. Bhardwaj Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion J. Immunol., December 15, 1999; 163(12): 6762 - 6768. [Abstract] [Full Text] [PDF]

				C. G. Tepper and M. F. Seldin Modulation of Caspase-8 and FLICE-Inhibitory Protein Expression as a Potential Mechanism of Epstein-Barr Virus Tumorigenesis in Burkitt's Lymphoma Blood, September 1, 1999; 94(5): 1727 - 1737. [Abstract] [Full Text] [PDF]

				X. Zang, M. Yazdanbakhsh, H. Jiang, M. R. Kanost, and R. M. Maizels A Novel Serpin Expressed by Blood-Borne Microfilariae of the Parasitic Nematode Brugia malayi Inhibits Human Neutrophil Serine Proteinases Blood, August 15, 1999; 94(4): 1418 - 1428. [Abstract] [Full Text] [PDF]

				R. D. Pettersen, K. Hestdal, M. K. Olafsen, S. O. Lie, and F. P. Lindberg CD47 Signals T Cell Death J. Immunol., June 15, 1999; 162(12): 7031 - 7040. [Abstract] [Full Text] [PDF]

				Y. Li, J. Kang, J. Friedman, L. Tarassishin, J. Ye, A. Kovalenko, D. Wallach, and M. S. Horwitz Identification of a cell protein (FIP-3) as a modulator of NF-kappa B activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha -induced apoptosis PNAS, February 2, 1999; 96(3): 1042 - 1047. [Abstract] [Full Text] [PDF]

				F. Messud-Petit, J. Gelfi, M. Delverdier, M.-F. Amardeilh, R. Py, G. Sutter, and S. Bertagnoli Serp2, an Inhibitor of the Interleukin-1beta -Converting Enzyme, Is Critical in the Pathobiology of Myxoma Virus J. Virol., October 1, 1998; 72(10): 7830 - 7839. [Abstract] [Full Text] [PDF]

				E. A. Atkinson, M. Barry, A. J. Darmon, I. Shostak, P. C. Turner, R. W. Moyer, and R. C. Bleackley Cytotoxic T Lymphocyte-assisted Suicide. CASPASE 3 ACTIVATION IS PRIMARILY THE RESULT OF THE DIRECT ACTION OF GRANZYME B J. Biol. Chem., August 14, 1998; 273(33): 21261 - 21266. [Abstract] [Full Text] [PDF]

				T. M. Antalis, M. La Linn, K. Donnan, L. Mateo, J. Gardner, J. L. Dickinson, K. Buttigieg, and A. Suhrbier The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon {alpha}/{beta} Priming J. Exp. Med., June 1, 1998; 187(11): 1799 - 1811. [Abstract] [Full Text] [PDF]

				M. J. Smyth and J. A. Trapani The Relative Role of Lymphocyte Granule Exocytosis versus Death Receptor-Mediated Cytotoxicity in Viral Pathophysiology J. Virol., January 1, 1998; 72(1): 1 - 9. [Full Text] [PDF]